Save up -80% on Cladribine
Note: this is a drug discount program, not an insurance plan.
Price of Cladribine
Cladribine 10 mg/10 ml vial
* price without discount in nearest pharmacy. Price may vary.
We offer free Cladribine coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your coupon in most local pharmacies to get a discount on Cladribine. Claim your prescription drug card now!
Cladribine volume of distribution
* 4.5 2.8 L/kg (patients with hematologic malignancies)
* 9 L/kg
What is Cladribine
An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia. (PubChem)
Cladribine mechanism of action
Cladribine is structurally related to fludarabine and pentostatin but has a different mechanism of action. Although the exact mechanism of action has not been fully determined, evidence shows that cladribine is phosphorylated by deoxycytidine kinase to the nucleotidecladribine triphosphate (CdATP; 2-chloro-2-deoxyadenosine 5-triphosphate), which accumulates and is incorporated into DNA in cells such as lymphocytes that contain high levels of deoxycytidine kinase and low levels of deoxynucleotidase, resulting in DNA strand breakage and inhibition of DNA synthesis and repair. High levels of CdATP also appear to inhibit ribonucleotide reductase, which leads to an imbalance in triphosphorylated deoxynucleotide (dNTP) pools and subsequent DNA strand breaks, inhibition of DNA synthesis and repair, nicotinamide adenine dinucleotide (NAD) and ATP depletion, and cell death. Unlike other antimetabolite drugs, cladribine has cytotoxic effects on resting as well as proliferating lymphocytes. However, it does cause cells to accumulate at the G1/S phase junction, suggesting that cytotoxicity is associated with events critical to cell entry into S phase. It also binds purine nucleoside phosphorylase (PNP), however no relationship between this binding and a mechanism of action has been established.
Dosage forms of Cladribine
Mylan Institutional LLC
Humans and other mammals
Indication of Cladribine
For the treatment of active hairy cell leukemia (leukemic reticuloendotheliosis) as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms. Also used as an alternative agent for the treatment of chronic lymphocytic leukemia (CLL), low-grade non-Hodgkin’s lymphoma, and cutaneous T-cell lymphoma.
Toxicity of Cladribine
Symptoms of overdose include irreversible neurologic toxicity (paraparesis/quadriparesis), acute nephrotoxicity, and severe bone marrow suppression resulting in neutropenia, anemia and thrombocytopenia.
Disclaimer: before buying a Cladribine on prescription, consult your health care provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.